| abstract |
The invention refers to a pharmaceutical compositionnsuitable for the protection of the mitochondrial genom and/ornmitochondrium from damages or for the treatment of diseasesnconnected with such damages, said composition comprising 0.1nto 95% by mass of a hydroximic acid derivative of the formulan nor a pharmaceutically acceptable acid addition salt thereof asnthe active ingredient in admixture with one or more conventionalncarrier(s). |